… Our results confirmed that the increasing incidence of thyroid cancer is largely limited to
papillary thyroid cancer—the subtype more likely to be found in a subclinical form and therefore …

… an important role in multiple cancers, certainly including papillary thyroid cancer [27–31].
By RT-qPCR analysis, we found GPX4 overexpressed in papillary thyroid cancer cell lines, …

… with iodine-131 in papillary thyroid cancer. These findings suggest that this BRAF mutation
may be a predictor of the efficacy of iodine-131 treatment for papillary thyroid cancer. …

… from an early tumor stage to a more aggressive cancer. While this process is widely accepted,
the ITH of early stage papillary thyroid carcinoma (PTC) is debated. By different genetic …

… Thyroid-stimulating hormones (TSHs) are associated with the risk of differentiated thyroid
cancer… We aimed to evaluate the relationship between pathological features of papillary thyroid …

… To identify eligible participants who perform thyroid surgery and/or treat patients with thyroid
cancer, we called provider’s offices by telephone to confirm eligibility and mailing address. …

… thyroid cancer has dramatically improved (2). The landmark study on PTC by The Cancer …
For example, BRAF V600E -mutant thyroid cancers tend to have a higher MAPK output than …

… prognosis of papillary thyroid cancer was established with a … The prognosis of papillary thyroid
cancer is very good after … -free survival for papillary thyroid cancer. A prognostic prediction …

… Papillary thyroid cancer (PTC) is the most common endocrine malignant tumor, representing
~90% of all thyroid cancers [1]. Although the detection and treatment methods have made …

Purpose Central lymph node metastasis (CNM) are highly prevalent but hard to detect
preoperatively in papillary thyroid carcinoma (PTC) patients, while the significance of prophylactic …